Next Evolution in Injection Treatment Arrives

Injection sets just became more convenient. We are proud to announce the release of ReadySharp injection sets, available for preorder on February 22, 2016.  Along with each enclosed FDA-approved drug comes a needle, syringe, and leak- and puncture-resistant sharps disposal.  Every tool you need for point-of-care treatment is at your fingertips.  Nitrile exam gloves, alcohol prep pads, povidone-iodine swabsticks, gauze, and an adhesive bandage are all sealed within a patented microbial film to prevent contamination. “We have developed an injection set that every physician can appreciate,” says James Maher, Chief Executive Officer and Founder.  “ReadySharp is a treatment that stresses convenience, but never sacrifices safety or quality.”

ReadySharp injection sets are assembled in an FDA-compliant, ISO-certified facility.  The finished products are stored in two state-of-the-art, temperature-controlled warehouses.  “We made it our mission to leave no stone unturned along the supply chain,” says Nick Nading, Vice President.  “Patient safety is always the top priority, even more so when prescription medicines are involved.”

With the initial launch of only four specific ReadySharp drug combinations, we are pleased to save you time and money.  Real market value was studied to determine the cost and reimbursement structures for each ReadySharp product. Logical rates accurately reflect the true price on each drug and non-drug component, which allows for consistent returns.

The unique, professionally designed logo is easily recognizable for clinics and distributors alike.  Created by engineers, ReadySharp packaging holds four treatment trays inside a dispenser box that looks great in your office. Cases of ReadySharp are sized perfectly for your bulk inventory.

Our main focus is providing high quality and innovative specialty pharmaceutical products to physicians and pharmacies. We are a rapidly-growing cGMP, FDA, and CFR-compliant company located in beautiful Reno-Tahoe.  As an established FDA-approved drug manufacturer, we provide healthcare practitioners with unique products aimed at treating patients safely, effectively, and enabling them to return to productivity as quickly and efficiently as possible. 

Terrain Pharmaceuticals has put in countless hours to bring you the most preferred injection sets on the market. Once you try the ReadySharp brand of injection sets, traditional kits will be a thing of the past. To learn more about why ReadySharp is the ideal fit for your business, please visit our newly unveiled website and preorder today!

For more information, call 877-985-8377 or email info@terrainrx.com for your ReadySharp™ pre-order today.

Opioid Addiction Facts

When most people think of pain relief, they assume ingesting a pill is the only option. However, there are many topical pain relievers on the market today such as ointments and patches. Topical Pain relievers are applied locally to skin or to specialized compartments of the body to modify pain by actions on sensory nerve endings and/or adjacent cellular elements. With this approach, there are low systemic drug levels, good tolerability, low addiction rates, and few drug interactions.

With many alternatives to narcotic pain relievers we are still seeing a wide range of our country addicted today.  Read through these staggering facts before you decide a pill is the only option to get relief.

Opioid Addiction Facts:

• Opioids are any of various compounds that bind to specific receptors in the central nervous system and have analgesic (pain relieving) effects including prescription medications such as oxycodone and hydrocodone and illicit substances such as heroin.
• Opioid addiction is federally described as a progressive, treatable brain disease.
• Any type of opioid can trigger latent chronic addiction brain disease.
• 24.6 million people 12 or older (9.4% of the population) live with substance dependence or abuse.
• 1.9 million Americans live with prescription opioid abuse or dependence.
• Opioid addiction disease occurs in every American State, County, socio-economic and ethnic group.
• 23% of heroin users develop chronic opioid addiction disease first.

National Opioid Overdose Epidemic:

• Over 100 Americans died from overdose deaths each day in 2013.
• 46 Americans die each day from prescription opioid overdoses; two deaths an hour, 17,000 annually.
• While illicit opioid heroin poisonings increased by 12.4% from 1999 to 2002, the number of prescription opioid analgesic poisonings in the United States increased by 91.2% during that same time period.
• Drug overdose was the leading cause of injury death in 2013, greater than car accidents and homicide.
• About 75% of opioid addiction disease patients switch to heroin as a cheaper opioid source.
• In 2012, 259 million opioid pain medication prescriptions were written, enough for every adult in America to have a bottle of pills.

Source: American Society of Addiction Medicine 

If you would like more information on Terrain Pharmaceutical products and what we are doing to help combat this epidemic, please contact us HERE.